Skip to content

Clinical trials

Memory Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20061
20091
20101
20141
20171
20211
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acumen Pharmaceuticals1
AstraZeneca1
Bayer1
Eisai Inc.1
GAP Innovations, PBC1
Ionis Pharmaceuticals, Inc.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Medivation, Inc.1
Merz Pharmaceuticals GmbH1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders11
Alzheimer Disease7
Cognitive Dysfunction4
Dementia4
Hypoglycemia1
Inflammation1
Neurodegenerative Diseases1
Pain1
Pick Disease of the Brain1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.